Company Announcements

Block listing Interim Review

Source: RNS
RNS Number : 3372K
UDG Healthcare Public Limited Co.
04 January 2021
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

 

 

Date: 4 January 2021

 

Name of applicant:

UDG HEALTHCARE PLC

Name of scheme:

UNITED DRUG PLC EXECUTIVE SHARE OPTION PLAN

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

201,100

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

27,500

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

173,600

         

 

Name of contact:

Damien Moynagh

Telephone number of contact:

+ 353 1 468 9000

 

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

Date: 4 January 2021

 

Name of applicant:

UDG HEALTHCARE PLC

Name of scheme:

UNITED DRUG PLC LONG TERM INCENTIVE PLAN

Period of return:

From:

1 July 2020

To:

30 December 2020

Balance of unallotted securities under scheme(s) from previous return:

2,133,538

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

349,121

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,784,417

         

 

Name of contact:

Damien Moynagh

Telephone number of contact:

+ 353 1 468 9000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBSBDDDXXDGGB